Agree Realty Announces Appointment of Ambassador John Rakolta Jr. to its Board of Directors
Get Alerts ADC Hot Sheet
Join SI Premium – FREE
BLOOMFIELD HILLS, Mich., Feb. 22, 2021 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that effective immediately Ambassador John Rakolta Jr. has rejoined the Company's Board of Directors (the "Board").
Ambassador Rakolta served on the Company's Board from 2011 until his confirmation as United States Ambassador to the United Arab Emirates in September 2019. Mr. Rakolta currently serves as the Chairman of Walbridge, one of the country's largest construction companies.
"We are extremely pleased to welcome John back to our Board of Directors," said Joey Agree, President and Chief Executive Officer. "His intellect, leadership, foresight and vision helped shape our Company and will be invaluable as we approach the next phase of Agree Realty's growth."
The Board has determined that Mr. Rakolta is independent in accordance with the NYSE listing standards and the Company's Corporate Governance Guidelines.
About Agree Realty Corporation
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of December 31, 2020, the Company owned and operated a portfolio of 1,129 properties, located in 46 states and containing approximately 22.7 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC". For additional information, please visit www.agreerealty.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/agree-realty-announces-appointment-of-ambassador-john-rakolta-jr-to-its-board-of-directors-301232046.html
SOURCE Agree Realty Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- V&V Supremo® Earns Top Honors at 2026 American Cheese Society Judging & Competition
- HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction
- 9 in 10 Parents Want Kids to Have Phone Access at School, Even as Phone Bans Sweep More Than 35 States
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share